Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Angeze 20 tablets
0206010K0BTAAAC
|
Angeze | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Angilol 40mg tablets
0204000R0BZABAJ
|
Angilol (Genesis Pharmaceuticals Ltd) | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Angilol 80mg tablets
0204000R0BZAAAK
|
Angilol (Genesis Pharmaceuticals Ltd) | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Angiopine 10 capsules
0206020R0BHABAB
|
Angiopine | Nifedipine | Cardiovascular System | No data available |
|
Angiopine MR 10mg tablets
0206020R0BHAEAE
|
Angiopine | Nifedipine | Cardiovascular System | No data available |
|
Angiopine MR 20mg tablets
0206020R0BHACAR
|
Angiopine | Nifedipine | Cardiovascular System | No data available |
|
Angiozem 60mg modified-release tablets
0206020C0BEAAAA
|
Angiozem | Diltiazem hydrochloride | Cardiovascular System | No data available |
|
Angiozem CR 120mg tablets
0206020C0BEACAS
|
Angiozem | Diltiazem hydrochloride | Cardiovascular System | No data available |
|
Angiozem CR 90mg tablets
0206020C0BEABAC
|
Angiozem | Diltiazem hydrochloride | Cardiovascular System | No data available |
|
Angitak 1.25mg/dose spray
0206010I0BWAAAM
|
Angitak | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Anglian Pharma 0.5% antiseptic first aid cream
1310050D0BJAAAA
|
Anglian Pharma | Cetrimide | Skin | No data available |
|
Anidulafungin 100mg inf vials
0502040A0AAAAAA
|
Anidulafungin | Anidulafungin | Infections | No data available |
|
Anidulafungin 100mg powder for solution for infusion vials
0502040A0AAABAB
|
Anidulafungin | Anidulafungin | Infections | No data available |
|
Aniflazym 5mg gastro-resistant tablets
1003010V0BBAAAA
|
Aniflazym | Serrapeptase | Musculoskeletal and Joint Diseases | No data available |
|
Anise oil liquid
190605000AAABAB
|
Generic compound preparation BNF 1906050 | Other oil preparations | Other Drugs and Preparations | No data available |
|
Anise water concentrated
190601000AAAAAA
|
Generic compound preparation BNF 1906010 | Other concentrated water preparations | Other Drugs and Preparations | No data available |
|
Antabuse 200mg tablets
0410010B0BBAAAA
|
Antabuse | Disulfiram | Central Nervous System | No data available |
|
Antacid & Oxetacaine oral suspension (old)
0101010N0AAAAAA
|
Antacid and oxetacaine | Aluminium and magnesium and oxetacaine | Gastro-Intestinal System | No data available |
|
Antazoline 2% ointment
1303000C0AAAAAA
|
Antaz hydrochloride (Topical) | Antazoline hydrochloride | Skin | No data available |
|
Antepsin 1g tablets
0103030S0BBAAAA
|
Antepsin | Sucralfate | Gastro-Intestinal System | No data available |
|
Antepsin 1g/5ml oral suspension
0103030S0BBABAD
|
Antepsin | Sucralfate | Gastro-Intestinal System | No data available |
|
Anthisan Plus Sting Relief spray
1303000B0BFAAAK
|
Anthisan Plus | Benzocaine | Skin | No data available |
|
Anthrax vaccine suspension for injection 0.5ml ampoules
1404000AUAAAAAA
|
Anthrax vaccine | Anthrax vaccine | Immunological Products and Vaccines | No data available |
|
Anthrax vaccine suspension for injection 5ml multidose vials
1404000AUAAABAB
|
Anthrax vaccine | Anthrax vaccine | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 1,250units/1ml inj pfs
1405030A0AAABAB
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.